Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow “in situ tumor vaccination”?
Crossref DOI link: https://doi.org/10.1007/s00262-017-2000-4
Published Online: 2017-04-13
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deplanque, Gaël
Shabafrouz, Keyvan
Obeid, Michel
Funding for this research was provided by:
INSERM
Université Pierre et Marie Curie
License valid from 2017-04-13